Morton Goldberg, Director at EYEGATE PHARMACEUTICALS INC (EYEG), sold 1,961 shares at $6.93 ($14K) on 2019-12-06, disclosed to the SEC on 2019-12-06.
Open-market sale of $14k EYEG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EYEG | SELL | 2016-06-15 | $47K | — | Filing → |
| EYEG | SELL | 2016-06-07 | $72K | — | Filing → |